We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OncoVista Innovative Therapies Inc (CE) | USOTC:OVIT | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 00:00:00 |
£
|
Rule 13d-1(b)
|
þ
|
Rule 13d-1(c)
|
£
|
Rule 13d-1(d)
|
CUSIP NO. 68232J105
|
13G A/1
|
|
||||||
1
|
NAME OF REPORTING PERSON
|
Wexford Spectrum Trading Limited
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
|||||||
3
|
SEC USE ONLY
|
|||||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Cayman Islands
|
||||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
|
0
|
|||||
6
|
SHARED VOTING POWER
|
1,714,284
|
||||||
7
|
SOLE DISPOSITIVE POWER
|
0
|
||||||
8
|
SHARED DISPOSITIVE POWER
|
1,714,284
|
||||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,714,284
|
||||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
|
|||||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
|
7.93%
|
||||||
12
|
TYPE OF REPORTING PERSON
|
CO
|
CUSIP NO. 68232J105
|
13G A/1
|
|
||||||
1
|
NAME OF REPORTING PERSON
|
Wexford Capital LP
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
|||||||
3
|
SEC USE ONLY
|
|||||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
|
0
|
|||||
6
|
SHARED VOTING POWER
|
1,714,284
|
||||||
7
|
SOLE DISPOSITIVE POWER
|
0
|
||||||
8
|
SHARED DISPOSITIVE POWER
|
1,714,284
|
||||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,714,284
|
||||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
|
|||||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
|
7.93%
|
||||||
12
|
TYPE OF REPORTING PERSON
|
PN
|
CUSIP NO. 68232J105
|
13G A/1
|
|
||||||
1
|
NAME OF REPORTING PERSON
|
Wexford GP LLC
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
|||||||
3
|
SEC USE ONLY
|
|||||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
|
0
|
|||||
6
|
SHARED VOTING POWER
|
1,714,284
|
||||||
7
|
SOLE DISPOSITIVE POWER
|
0
|
||||||
8
|
SHARED DISPOSITIVE POWER
|
1,714,284
|
||||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,714,284
|
||||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
|
|||||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
|
7.93%
|
||||||
12
|
TYPE OF REPORTING PERSON
|
OO
|
CUSIP NO. 68232J105
|
13G A/1
|
|
||||||
1
|
NAME OF REPORTING PERSON
|
Charles E. Davidson
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
|||||||
3
|
SEC USE ONLY
|
|||||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
United States
|
||||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
|
0
|
|||||
6
|
SHARED VOTING POWER
|
1,714,284
|
||||||
7
|
SOLE DISPOSITIVE POWER
|
0
|
||||||
8
|
SHARED DISPOSITIVE POWER
|
1,714,284
|
||||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,714,284
|
||||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
|
|||||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
|
7.93%
|
||||||
12
|
TYPE OF REPORTING PERSON
|
IN
|
CUSIP NO 68232J105
|
13G A/1
|
|
||||||
1
|
NAME OF REPORTING PERSON
|
Joseph M. Jacobs
|
||||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
|||||||
3
|
SEC USE ONLY
|
|||||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
United States
|
||||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
|
0
|
|||||
6
|
SHARED VOTING POWER
|
1,714,284
|
||||||
7
|
SOLE DISPOSITIVE POWER
|
0
|
||||||
8
|
SHARED DISPOSITIVE POWER
|
1,714,284
|
||||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,714,284
|
||||||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
|
|||||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
|
7.93%
|
||||||
12
|
TYPE OF REPORTING PERSON
|
IN
|
|
Item
1. should be deleted in its entirety and replaced with the following:
|
(a)
|
Name of Issuer:
|
(b)
|
Address of Issuer’s Principal Executive Offices:
|
|
14785 Omicron Drive, Suite 104
|
|
San Antonio, TX 78245
|
|
(a)
|
Name of Persons Filing (collectively, the “
Reporting Persons
”):
|
(i)
|
Wexford Spectrum Trading Limited
|
(ii)
|
Wexford Capital LP
|
(iii)
|
Wexford GP LLC
|
(iv)
|
Charles E. Davidson
|
(v)
|
Joseph M. Jacobs
|
|
(b)
|
Address of Principal Business Office, or, if none, Residence of Reporting Persons:
|
|
(c)
|
Citizenship:
|
(i)
|
Wexford Spectrum Trading Limited – Cayman Islands
|
(ii)
|
Wexford Capital LP – Delaware
|
(iii)
|
Wexford GP LLC - Delaware
|
(iv)
|
Charles E. Davidson - United States
|
(v)
|
Joseph M. Jacobs – United States
|
|
(d)
|
Title of Class of Securities:
|
|
(e)
|
CUSIP Number:
|
|
68232J105
|
|
Item 4
should be deleted in its entirety and replaced with the following:
|
|
Item 4
Ownership
|
|
(i) Wexford Spectrum Trading Limited
|
|
(a)
|
Amount beneficially owned: 1,714,284
|
|
(b)
|
Percent of class: 7.93%
|
|
(c)
|
Number of shares to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
|
(ii)
|
Shared power to vote or to direct the vote: 1,714,284
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 0
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 1,714,284
|
|
(ii) Wexford Capital LP
|
|
(a)
|
Amount beneficially owned: 1,714,284
|
|
(b)
|
Percent of class: 7.93%
|
|
(c)
|
Number of shares to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
|
(ii)
|
Shared power to vote or to direct the vote: 1,714,284
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 0
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 1,714,284
|
|
(iii) Wexford GP LLC
|
|
(a)
|
Amount beneficially owned: 1,714,284
|
|
(b)
|
Percent of class: 7.93%
|
|
(c)
|
Number of shares to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
|
(ii)
|
Shared power to vote or to direct the vote: 1,714,284
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 0
|
(iv)
|
Shared power to dispose or to direct the disposition of: 1,714,284
|
|
(iv) Charles E. Davidson
|
|
(a)
|
Amount beneficially owned: 1,714,284
|
|
(b)
|
Percent of class: 7.93%
|
|
(c)
|
Number of shares to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
|
(ii)
|
Shared power to vote or to direct the vote: 1,714,284
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 0
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 1,714,284
|
|
(v) Joseph M. Jacobs
|
|
(a)
|
Amount beneficially owned: 1,714,284
|
|
(b)
|
Percent of class: 7.93%
|
|
(c)
|
Number of shares to which the person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 0
|
|
(ii)
|
Shared power to vote or to direct the vote: 1,714,284
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 0
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 1,714,284
|
Date: February 14, 2014
|
Company Name
|
||
WEXFORD SPECTRUM TRADING LIMITED
|
|||
By:
|
/s/ Arthur H. Amron
|
||
Name:
|
Arthur H. Amron
|
||
Title:
|
Vice President and Assistant Secretary
|
||
WEXFORD CAPITAL LP
|
|||
By:
|
Wexford GP LLC, its General Partner
|
||
By:
|
/s/ Arthur H. Amron
|
||
Name:
|
Arthur H. Amron
|
||
Title:
|
Vice President and Assistant Secretary
|
||
WEXFORD GP LLC
|
|||
By:
|
/s/ Arthur H. Amron
|
||
Name:
|
Arthur H. Amron
|
||
Title:
|
Vice President and Assistant Secretary
|
||
/s/ Joseph M. Jacobs
|
|||
JOSEPH M. JACOBS
|
|||
/s/ Charles E. Davidson
|
|||
CHARLES E. DAVIDSON
|
|||
1 Year OncoVista Innovative The... (CE) Chart |
1 Month OncoVista Innovative The... (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions